Literature DB >> 27247343

Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines.

Thomas J Scriba1, Stefan H E Kaufmann2, Paul Henri Lambert3, Melvin Sanicas4, Carlos Martin5, Olivier Neyrolles6.   

Abstract

Live attenuated and killed whole-cell vaccines (WCVs) offer promising vaccination strategies against tuberculosis. A number of WCV candidates, based on recombinant bacillus Calmette-Guerin (BCG), attenuated Mycobacterium tuberculosis, or related mycobacterial species are in various stages of preclinical or clinical development. In this review, we discuss the vaccine candidates and key factors shaping the development pathway for live and killed WCVs and provide an update on progress.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  BCG; tuberculosis; vaccine; whole-cell vaccine

Mesh：

Substances：

Year:  2016        PMID： 27247343     DOI： 10.1093/infdis/jiw228

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  15 in total

1.  Mycobacterium tuberculosis sigE mutant ST28 used as a vaccine induces protective immunity in the guinea pig model.

Authors:  JoLynn Troudt; Elizabeth Creissen; Linda Izzo; Helle Bielefeldt-Ohmann; Stefano Casonato; Riccardo Manganelli; Angelo A Izzo
Journal:  Tuberculosis (Edinb)       Date:  2017-07-24       Impact factor: 3.131

Review 2.  Moving tuberculosis vaccines from theory to practice.

Authors:  Peter Andersen; Thomas J Scriba
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

3.  Validation of a CD1b tetramer assay for studies of human mycobacterial infection or vaccination.

Authors:  Erik D Layton; Krystle K Q Yu; Malisa T Smith; Thomas J Scriba; Stephen C De Rosa; Chetan Seshadri
Journal:  J Immunol Methods       Date:  2018-04-21       Impact factor: 2.303

Review 4.  MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic.

Authors:  Jesus Gonzalo-Asensio; Dessislava Marinova; Carlos Martin; Nacho Aguilo
Journal:  Front Immunol       Date:  2017-12-15       Impact factor: 7.561

Review 5.  Novel vaccination approaches to prevent tuberculosis in children.

Authors:  James A Triccas; Claudio Counoupas
Journal:  Pneumonia (Nathan)       Date:  2016-11-24

6.  Antibody to Poly-N-acetyl glucosamine provides protection against intracellular pathogens: Mechanism of action and validation in horse foals challenged with Rhodococcus equi.

Authors:  Colette Cywes-Bentley; Joana N Rocha; Angela I Bordin; Mariana Vinacur; Safia Rehman; Tanweer S Zaidi; Mark Meyer; Sarah Anthony; McKenzie Lambert; Daniel R Vlock; Steeve Giguère; Noah D Cohen; Gerald B Pier
Journal:  PLoS Pathog       Date:  2018-07-19       Impact factor: 6.823

Review 7.  What Have We Learnt about BCG Vaccination in the Last 20 Years?

Authors:  Hazel M Dockrell; Steven G Smith
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

8.  Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host.

Authors:  Andy Alhassan; Huitao Liu; Jodi McGill; Argine Cerezo; Laxmi U M R Jakkula; Arathy D S Nair; Emma Winkley; Sally Olson; Denver Marlow; Abha Sahni; Hema P Narra; Sanjeev Sahni; Jamie Henningson; Roman R Ganta
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

9.  Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy.

Authors:  Bryan E Hart; Sunhee Lee
Journal:  PLoS Negl Trop Dis       Date:  2016-12-12

Review 10.  CD1: From Molecules to Diseases.

Authors:  D Branch Moody; Sara Suliman
Journal:  F1000Res       Date:  2017-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.